April 29, 2020
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reported that data from an international clinical trial testing the broad-spectrum antiviral drug remdesivir showed “quite good news” and should result in a new standard of care for COVID-19 patients. Remdesivir was co-developed by researchers in the Baric Lab at the UNC Gillings School of Global Public Health.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
